Showing 26–50 of 200 documents
Sorted by hybrid relevance (keyword + semantic via RRF)
Yao S, Yan J, Li L, Ma D, Liu J, et al.
Background Multidrug-resistant tuberculosis (MDR-TB) is currently a major problem in China. The prevention and treatment work for MDR-TB patients started late in Anhui province. To determine the prevalence of MDR-TB in sputum smear-positive TB patients (SSPTBPs) and analyze the r…
Asamblea Mundial de la Salud, 63
Consejo Ejecutivo, 126
O.I. Sakhelashvili–Bil
Objective — to study the features of multidrug-resistant tuberculosis of the lungs of respiratory organs in children and adolescents from focuses of chemoresistant tuberculosis infection. 
 Materials and methods. To study the features of the course of multidrug-resistant pul…
Ogwang MO, Imbuga M, Ngugi C, Mutharia L, Magoma G, et al.
Introduction Globally anti-tuberculosis drug resistance is one of the major challenges affecting control and prevention of tuberculosis. Kenya is ranked among 30 high burden TB countries globally. However, there is scanty information on second line antituberculosis drug resistanc…
Leonardo Martínez, Neus Altet, F Boulahbal, Joan A. Caylà, Tsira Chakhaia, et al.
…t Objective To evaluate the impact of isoniazid on incident tuberculosis in household contacts of MDR tuberculosis cases. Design Systematic review and individual-participant meta-analysis. Data sources MEDLINE, Web of Science, BIOSIS, and Embase without language restrictions for …
Engel N, Ochodo EA, Karanja PW, Schmidt BM, Janssen R, et al.
…kground Programmes that introduce rapid molecular tests for tuberculosis and tuberculosis drug resistance aim to bring tests closer to the community, and thereby cut delay in diagnosis, ensure early treatment, and improve health outcomes, as well as overcome problems with poor la…
Gebremariam G, Kiros M, Hagos S, Hadush H, Gebremichael A, et al.
Background Tuberculosis (TB) is a major public health concern in the developing countries. Moreover, the emergence of multidrug-resistant tuberculosis is challenging. However, there are no organized data on the trends of pulmonary tuberculosis and rifampicin-resistant Mycobacteri…
Ali MM, Weldegebreal F, Kabew G, Urgesa K
Background Multi-drug resistant Mycobacterium tuberculosis is a growing public health problem in developing countries including Somalia. Although, the prevalence of multi-drug resistant tuberculosis among new and retreated cases is high, data on GeneXpert- Mycobacterium tuberculo…
World Health Organization, Solans, Belén P., Béranger, Agathe, Radtke, Kendra, Mohamed, Ali, et al.
World Health Organization, Haigh, Kathryn, Twabi, Hussein, Ryan, Hannah, Lutje, Vittoria, et al.
A. A. Abdurakhimov
Aim. To conduct a comparative study of the effectiveness of treatment of MDR-TB patients by using short-term and individual chemotherapy regimens and including the drug Cholecalciferol in the treatment complex. Material and methods. The group of MDR-TB patients with a short-term …
Vyawahare C, Mukhida S, Khan S, Gandham NR, Kannuri S, et al.
Introduction Tuberculosis remains a global health problem worldwide and the risk progression of Tuberculosis to Drug Resistant Tuberculosis is influenced by various factors. These include immunocompromised status, past history of tuberculosis, life style and nutritional level. He…
Ayenew Berhan, Bekele Sharew, Andargachew Almaw, Shewaneh Damtie, Biruk Legese, et al.
**BACKGROUND AND AIMS:** Tuberculosis is a major infectious disease that affects hematological profiles. However, limited data assess changes in hematological profiles among patients with pulmonary and multidrug-resistant tuberculosis. Therefore, this study aimed to compare the h…
Boosra Harun Prima, Md Ehsanul Hoque, Shakeel Ahmed, Md. Zakir Hossain, Sharmin Akhtar, et al.
Background: Tuberculosis (TB) remains one of the deadliest communicable diseases. Tuberculosis is caused by Mycobacterium tuberculosis and classified as Pulmonary Tuberculosis (PTB) and Extra Pulmonary Tuberculosis (EPTB). EPTB account for 15-20 % cases of tuberculosis. EPTB diag…
Kasim Izebe, Kolo Ibrahim, Josiah Ademola Onaolapo, Peters Oladosu, Y. Ya’aba, et al.
The management, control and elimination of tuberculosis (TB) have been difficult with the advent of HIV and cases of multidrug resistant (MDR-TB) tuberculosis. The cases of multidrug resistance to rifampicin and isoniazid pose greater challenges on first line and second line drug…
A. A. Zhurilo, A. I. Barbova, Yu. A. Cherednik, P. S. Trofimova, S. V. Mironchenko, et al.
…RPLUS STRIPS FOR DETECTION OF MUTATIONS, ASSOCIATED WITH M. TUBERCULOSIS RESISTANCE TO RIFAMPICIN IN TUBERCULOSIS A. A. Zhurilo, A. I. Barbova, Yu. A. Cherednik, P. S. Trofi mova, S. V. Mironchenko, O. V. Pavlova, A. V. Chernov, L. M. Sladkova Summary The aim was to analyze the l…
Tierney DB, Orvis E, Nathavitharana RR, Hurwitz S, Tintaya K, et al.
…ly, Separate safely, Treat effectively) strategy on time to tuberculosis diagnosis and treatment for patients at a general hospital in a tuberculosis-endemic setting. Design Prospective cohort study with historical controls. Participants Patients diagnosed with pulmonary tubercul…
Merid Y, Hailu E, Habtamu G, Tilahun M, Abebe M, et al.
Introduction Understanding the epidemiology of tuberculosis is limited by lack of genotyping data. We sought to characterize the drug susceptibility testing patterns and genetic diversity of M. tuberculosis isolates in southern Ethiopia. Methodology A cross-sectional study was co…
Ali S, Khan MT, Khan AS, Mohammad N, Khan MM, et al.
Anti-tuberculosis therapy involves the combination of drugs to hamper the growth of Mycobacterium tuberculosis (MTB). The emergence of multidrug-resistant tuberculosis (MDR-TB) is a global concern. Pakistan has been ranked 5 th position in terms of a high burden of MDR-TB in the …
Rehbar Khan, Munish Ahmad, Santosh Raghav
Background: Multidrug-resistant tuberculosis (MDR-TB) prevalence is increasing throughout the world. Although, most important risk factor for development of MDR-TB is inadequate and irregular previous treatment for tuberculosis, but newly treated patients are also at risk due to …
Nindrea RD, Sari NP, Harahap WA, Haryono SJ, Kusnanto H, et al.
… data presents a survey data describing multidrug-resistant tuberculosis, tuberculosis patients characteristics and stress resilience during COVID-19 pandemic in West Sumatera Province, Indonesia. The data were gathered from multidrug-resistant tuberculosis, tuberculosis patients…
Djika M, Koudokpon CH, Dougnon VT, Sanoussi N, Alphazazi S, et al.
Introduction tuberculosis remains a major public health problem, with continuing high levels of prevalence, and mortality. In Niger, the incidence of tuberculosis remains high. This study aims to investigate the epidemiology of pulmonary tuberculosis at the National Anti-Tubercul…
Alloysius Chibuike Ogodo, Verwiyeh Silas Tatah, Francis Ushie Ebuara, Chidera Favour Ogodo
This chapter introduces Mycobacterium tuberculosis , the agent that causes tuberculosis and the drugs (first- and second-line) for tuberculosis treatment as well as the effects of phytochemicals against Mycobacterium tuberculosis . It starts by giving an overview of the organism …
Kahase D, Desta K, Yaregal Z, Yenew B, Driba G, et al.
…ing Ethiopia. Hence, we aimed to assess the magnitude of M. tuberculosis and nontuberculous mycobacteria (NTM) among presumptive pulmonary tuberculosis patients attending St. Paul's hospital Medical College, Addis Ababa, Ethiopia. Methods A cross-sectional study was conducted fro…